/Lists

Biotech Investors & VC Firms in United States

1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.

ACME Capital
San FranciscoPre-Seed–Growth
13 people
Montage Capital
CampbellGrowth
5 people
Berkeley Frontier
BerkeleySeed–Late Stage
39 people
Cross Creek Advisors
Salt Lake CitySeries B–Late Stage
21 people
Prototype Capital
Los AngelesPre-Seed–Seed
38 people
Allen Institute for AI (AI2) Incubator
SeattlePre-Seed–Seed$100K – $600K
22 people
AIF
New YorkSeed–Growth
39 people
SAV (Scale Asia Ventures)
Palo AltoPre-Seed–Growth$100K – $25M
16 people
Compound
New YorkSeed–Series A$400K – $1.5M
14 people
Kaiser Permanente Ventures
San FranciscoSeed–Growth$2M – $5M
14 people
Two Bear Capital
WhitefishPre-Seed–Series B$3M – $10M
34 people
AIX Ventures
San FranciscoPre-Seed–Series A$1M – $5M
12 people
FoundersX Ventures
Silicon ValleySeed–Series A
18 people
RoundTable Healthcare Partners
Lake ForestGrowth
36 people
GOOSE Capital
HoustonPre-Seed–Series A
37 people
IU Ventures
BloomingtonPre-Seed–Series A
18 people
A-Level Capital
BaltimorePre-Seed–Series B$40K – $100K
40 people
ARCHIMED Japan
New YorkGrowth$11M – $1.1B
24 people
Frist Cressey Ventures
NashvilleSeed–Series A$500K – $20M
23 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
Avoro Capital Advisors
New YorkSeries A–Late Stage
22 people
Dreamers VC
El SegundoSeed–Series B$500K – $5M
10 people
Delaware Crossing Investor Group
PhiladelphiaSeed–Series A
24 people
Rising Tide
PacificaSeed–Series A
12 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.